Home › Type 2 Diabetes › NCT07065721

Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

CAPAZ-2D: Continuous Glucose Monitoring to Augment and Personalize Self-Management of Type 2 Diabetes in Hispanic/Latinx Young Adults

Who can join

Ages 18 to 45 · All sexes

Inclusion Criteria:

* adult 18-45 years of age
* diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record
* no prior use or experience with wearable CGMs
* possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app
* fluency in English or Spanish

Exclusion Criteria:

* severe mental illness (e.g., psychosis, suicidal ideation);
* pregnancy or \<6 months postpartum

About the study

Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.

What is being tested

• Continuous glucose monitor (device)

Sponsor: San Diego State University · Participants: 40 · Started: Oct 2, 2025

Contact the study team

• Jessica L McCurley, PhD, MPH · Phone: 619-594-2132

Official record on ClinicalTrials.gov — NCT07065721

Locations in the U.S.

Conditions

• Type 2 Diabetes

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.